Skip to main navigation
  • Company
    • About Us
    • Leadership
    • Collaboration
    • Contact
  • Pipeline
    • Pipeline
    • Clinical Trials
  • Technology
    • Multiclonics® Platform
    • Publications
  • Investors & Media
    • Investors & Media Home
    • Financial Information
      • SEC Filings
      • Extraordinary General Meeting December 2019
      • Extraordinary General Meeting December 2019
      • Annual General Meeting 2019
      • Annual General Meeting 2018
      • Annual General Meeting 2017
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
      • Governance Contacts
      • Governance Documents
    • News Releases
    • Event Calendar
    • Analyst Coverage
    • Stock Information
    • FAQ's
    • Email Alerts
  • Careers
Menu
 

Annual General Meeting 2019

SubNav - Financial Information

  • SEC Filings
  • Annual General Meeting 2020
  • Extraordinary General Meeting December 31, 2019
  • Extraordinary General Meeting December 2019
  • Annual General Meeting 2019
  • Annual General Meeting 2018
  • Annual General Meeting 2017

Annual General Meeting 2019

Minutes AGM 2019
May 22, 2019
Voting Results AGM 2019
May 22, 2019
Convening Notice with Agenda and Explanatory Notes (AGM 2019)
May 22, 2019
Merus N.V. – Annual Accounts and Report 2018
May 22, 2019
Proposed Articles of Association - Merus N.V.
May 22, 2019
Works Council Statement
May 22, 2019
Voting Proxy (AGM 2019)
May 22, 2019

Toolkit

  • RSS Feeds
  • E-mail Page
  • Print Page
  • E-mail Alerts
Explore
  • Company
  • Pipeline
  • Technology
  • Investors & Media
  • Careers
  • Contact
Contact Us

NL: +31 85 016 2500
Merus N.V., Yalelaan 62, 3584 CM Utrecht, The Netherlands
US: +1 617 401 4499
139 Main Street, Cambridge, MA 02142, USA
enquiries@merus.nl

© 2021 Merus - All rights reserved. Privacy Statement, Online Tracking Opt-Out Guide, Terms of Use & Community Guidelines.